City

Brussels (1)

Winston-Salem (1)

Condition

Hypopharynx Squamous Cell Carcinoma (2)

Larynx Squamous Cell Carcinoma (2)

Oral Cavity Squamous Cell Carcinoma (2)

Oropharynx Squamous Cell Carcinoma (2)

Head Neck Cancer (1)

Metastatic Squamous Cell Carcinoma (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 2 (2)

Sponsor

Cliniques universitaires Saint-Luc- Universite Catholique de Louvain (1)

Wake Forest University Health Sciences (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

carboplatin (1)

io102 (1)

io103 (1)

paclitaxel (1)

pembrolizumab (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

Other (2)

Study Type

Interventional (2)

larynx squamous cell carcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Head Neck Cancer, Metastatic Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Winston-Salem (Pembrolizumab,

Recruiting

Head Neck Cancer
+5 more

Pembrolizumab
+2 more

Winston-Salem, North Carolina

Wake Forest Baptist Health Sciences

Aug 8, 2022

Oropharynx Squamous Cell Carcinoma, Larynx Squamous Cell Carcinoma, Hypopharynx Squamous Cell Carcinoma Trial in Brussels

Recruiting

Oropharynx Squamous Cell Carcinoma
+3 more

IO102
IO103

Brussels, Belgium

Cliniques Universitaires Saint-Luc

May 6, 2022